1-15 of 20
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
CME/CESpotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
Incorporating Targeted Therapies in Treatment Planning for AAV
CME/CEIncorporating Targeted Therapies in Treatment Planning for AAV
- advertisement
Gout Beyond the Joints: What’s the Hidden Danger?
MinuteCE®Gout Beyond the Joints: What’s the Hidden Danger?
Is Managing Gout in the Nephrology Clinic a Challenge?
MinuteCE®Is Managing Gout in the Nephrology Clinic a Challenge?
Center of the Target: Which Patients Are Most Likely to Develop Gout?
MinuteCE®Center of the Target: Which Patients Are Most Likely to Develop Gout?
Treat or Refer: Who Is Responsible for Managing Gout?
MinuteCE®Treat or Refer: Who Is Responsible for Managing Gout?
Can You Manage Patients With Uncontrolled Gout More Effectively?
MinuteCE®Can You Manage Patients With Uncontrolled Gout More Effectively?
- advertisement
What’s New About Gout? Rheumatology Perspective
MinuteCE®What’s New About Gout? Rheumatology Perspective
What Are the Emerging Therapies for Managing Gout?
MinuteCE®What Are the Emerging Therapies for Managing Gout?
